Alfuzosin - CAS 81403-80-7
Catalog number:
81403-80-7
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C19H27N5O4
Molecular Weight:
389.45
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Alfuzosin is a pharmaceutical drug of the alpha-1 blocker class. It works by relaxing the muscles in the prostate and bladder neck. It is used to treat benign prostatic hyperplasia (BPH). It offers an alternative to prostatectomy in patients who require surgery but are unfit for this treatment, and in patients requiring symptomatic relief while awaiting surgery. It is marketed in the United States by Sanofi Aventis under the brand name Uroxatral. It was approved by the FDA for treatment of BPH in June 2003. It has been approved the listing.
Publictions citing BOC Sciences Products
  • >> More
Purity:
99%
Appearance:
Solid powder
Synonyms:
Alfuzosina;Alfuzosine;Xatral;2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-;N-[3-[N-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-N-(methyl)amino]propyl]tetrahydrofuran-2-carboxamide;SL 77499;Alfuzosinum
Solubility:
DMSO 85 mg/mL (199 mM); Water 85 mg/mL (199 mM)
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Alfuzosin is used to treat benign prostatic hyperplasia (BPH).
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Grams to Kilograms
Melting Point:
178-180 °C
Density:
1.272±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
WNMJYKCGWZFFKR-UHFFFAOYSA-N
InChI:
InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)
Canonical SMILES:
CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
Current Developer:
Alfuzosin is marketed in the United States by Sanofi Aventis under the brand name Uroxatral. It was approved by the FDA for treatment of BPH in June 2003. It has been approved the listing.
1.Assessment of column selection systems using Partial Least Squares.
Žuvela P1, Liu JJ2, Plenis A3, Bączek T3. J Chromatogr A. 2015 Nov 13;1420:74-82. doi: 10.1016/j.chroma.2015.09.085. Epub 2015 Oct 1.
Column selection systems based on calculation of a scalar measure based on Euclidean distance between chromatographic columns, suffer from the same issue. For diverse values of their parameters, identical or near-identical values can be calculated. Proper use of chemometric methods can not only provide a remedy, but also reveal underlying correlation between them. In this work, parameters of a well-established column selection system (CSS) developed at Katholieke Universiteit Leuven (KUL CSS) have been directly correlated to parameters of selectivity (retention time, resolution, and peak/valley ratio) toward pharmaceuticals, by employing Partial Least Squares (PLS). Two case studies were evaluated, separation of alfuzosin, lamotrigine, and their impurities, respectively. Within them, comprehensive correlation structure was revealed, which was thoroughly interpreted, confirming a causal relationship between KUL parameters and parameters of column performance.
2.Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride.
Rudraswamy-Math NR1, Gupta VR1. Pak J Pharm Sci. 2015 Nov;28(6):2147-52.
Alfuzosin hydrochloride is a novel drug used in the treatment of urinary incontinency. The purpose of this research was to develop controlled release floating matrix formulations of Alfuzosin HCl. Floating matrix tablets of Alfuzosin HCl were prepared using hydroxypropyl methylcellulose (HPMC), Polyethylene oxide (PEO), Carbopol 971P NF polymer (Direct compressible) and Blend of Polyvinyl Acetate and Povidone 30 (80:19:1(0.8% sodium laury sulfate and 0.2% silica)). Combination of citric acid and sodium bicarbonate were also used as gas forming agent. Matrix formulations were prepared by direct compression method and evaluated for floating, in vitro drug release profile and swelling characteristics. The mechanism of drug release was found to follow non-Fickian or anomalous type. The data obtained from the invitro release studies demonstrated that the floating matrix tablets containing HPMC 100K CR (controlled-release) and carbopol along with sodium CMC were found to sustain the release of drug over a period of 12 hours.
3.Temperature influencing permeation pattern of alfuzosin: an investigation using DoE.
Pattnaik S1, Swain K2, Rao JV2, Varun T2, Mallick S3. Medicina (Kaunas). 2015;51(4):253-61. doi: 10.1016/j.medici.2015.07.002. Epub 2015 Jul 30.
BACKGROUND AND OBJECTIVE: There has been relatively little investigation of the effect of temperature on skin permeation compared to other methods of penetration enhancement. A principal physicochemical factor which controls the passive diffusion of a solute from a vehicle into the skin arises from the skin temperature. The aim of this ex vivo study was to probe into the effect of heat on transdermal absorption of alfuzosin hydrochloride from ethyl cellulose-polyvinyl pyrrolidone (EC-PVP) based transdermal systems.
4.Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
Forbes A1, Anoopkumar-Dukie S2, Chess-Williams R1, McDermott C1. Prostate. 2016 Feb 16. doi: 10.1002/pros.23167. [Epub ahead of print]
BACKGROUND: Some α1 -adrenoceptor antagonists possess anti-cancer actions that are independent of α1 -adrenoceptors and the aim of these studies was to assess the relative cytotoxic potencies of α1 -adrenoceptor antagonists and the mechanisms involved in these actions.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 152520-56-4 Nebivolol

Nebivolol
(CAS: 152520-56-4)

Nebivolol selectively inhibits β1-adrenoceptor with IC50 of 0.8 nM.

CAS 116209-55-3 Levobetaxolol HCl

Levobetaxolol HCl
(CAS: 116209-55-3)

Levobetaxolol exhibits a higher affinity at cloned human β1 and β2 receptors with Ki value of 0.76 nM and 32.6 nM, respectively.

CAS 56392-17-7 Metoprolol Tartrate

Metoprolol Tartrate
(CAS: 56392-17-7)

Metoprolol Tartrate is a cardioselective β-adrenergic receptor blocker with IC50 of 42 ng/mL.

CAS 161905-64-2 α1 adrenoceptor-MO-1

α1 adrenoceptor-MO-1
(CAS: 161905-64-2)

An S enantiomer which has affinity at alpha 1 adrenergic receptor

CAS 856620-39-8 O-desmethyl Mebeverine alcohol hydrochloride

O-desmethyl Mebeverine alcohol hydrochlo
(CAS: 856620-39-8)

O-desmethyl Mebeverine alcohol hydrochloride, a metabolite of Mebeverine, is a potent inhibitor of α1 repector, causing relaxation of the gastrointestinal tract...

CAS 59803-98-4 Brimonidine

Brimonidine
(CAS: 59803-98-4)

Brimonidine is α2-Adrenoceptor agonist. It is a drug used as eye drops to treat open-angle glaucoma or ocular hypertension. It acts via decreasing synthesis of ...

CAS 550-99-2 Naphazoline hydrochloride

Naphazoline hydrochloride
(CAS: 550-99-2)

Naphazoline hydrochloride is an ocular vasoconstrictor used in eye drops.

CAS 32780-64-6 labetalol hydrochloride

labetalol hydrochloride
(CAS: 32780-64-6)

Labetalol HCl is a dual antagonist for both selective alpha1-adrenergic and nonselective beta-adrenergic receptors, used in the treatment of high blood pressure...

CAS 85700-55-6 Scopine HCl

Scopine HCl
(CAS: 85700-55-6)

Scopine HCl is the hydrochloride of Scopine, which is the metabolite of anisodine, which is a α1-adrenergic receptor agonist and used in the treatment of acute ...

CAS 81403-80-7 Alfuzosin

Alfuzosin
(CAS: 81403-80-7)

Alfuzosin is a pharmaceutical drug of the alpha-1 blocker class. It works by relaxing the muscles in the prostate and bladder neck. It is used to treat benign p...

CAS 847829-38-3 Rezatomidine

Rezatomidine
(CAS: 847829-38-3)

Rezatomidine is a selective α2-adrenoreceptor antagonist under the development of Allergan. No recent development was reported for the treatment of Diabetic neu...

CAS 51-30-9 Isoprenaline HCl

Isoprenaline HCl
(CAS: 51-30-9)

Isoprenaline is a non-selective beta-adrenergic receptor agonist, used for the treatment of bradycardia and heart block. It would increase cAMP levels and activ...

CAS 71576-40-4 Aptazapine

Aptazapine
(CAS: 71576-40-4)

Aptazapine is a tetracyclic antidepressant. It was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. Aptazapine is...

CAS 83688-84-0 Tertatolol

Tertatolol
(CAS: 83688-84-0)

Tertatolol, a benzothiopyran derivative, is a potent dual antagonist of beta-adrenoceptor and 5-HT receptor, with antihypertensive effect.

CP 59430
(CAS: 86329-06-8)

CP 59430 is an azide analog of prazosin. It is a selective alpha 1-adrenergic receptor antagonist.

CAS 106463-17-6 Tamsulosin HCl

Tamsulosin HCl
(CAS: 106463-17-6)

The hydrochloride salt form of Tamsulosin which could block on the sympathetic α1 receptor, especially selectively bind to the α1A receptor so that has been fou...

CAS 26921-17-5 Timolol Maleate

Timolol Maleate
(CAS: 26921-17-5)

Timolol Maleate is a non-selective, beta-adrenergic receptor antagonist for β1/β2 with Ki of 1.97 nM/2.0 nM.

CAS 63590-64-7 Terazosin

Terazosin
(CAS: 63590-64-7)

Terazosin, works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls, is a selective alpha1-antagonist used for trea...

CAS 34381-68-5 Acebutolol hydrochloride

Acebutolol hydrochloride
(CAS: 34381-68-5)

Acebutolol is a β-adrenergic receptors antagonist used in the treatment of hypertension, angina pectoris and cardiac arrhythmias.

CAS 57149-07-2 Naftopidil

Naftopidil
(CAS: 57149-07-2)

Naftopidil is a selective α1-adrenergic receptor antagonist or alpha blocker with a Ki of 58.3 nM.

Chemical Structure

CAS 81403-80-7 Alfuzosin

Quick Inquiry

Verification code

Featured Items